The Stony Brook School

The Inner Circle Acknowledges, Paul Byrne, MD, FACOG as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology

Retrieved on: 
Thursday, December 14, 2023
Inner circle, SUNY, Private practice, Cornell University, Gynaecology, Bachelor, The Stony Brook School, Patient, Multimedia, NYU, Medical degree, MD, FACOG, Obstetrics, AOA, Education, Philosophy, Nursing, Medicine

MINEOLA, N.Y., Dec. 14, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul Byrne, MD, FACOG is acknowledged as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology.

Key Points: 
  • MINEOLA, N.Y., Dec. 14, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul Byrne, MD, FACOG is acknowledged as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology.
  • Dr. Byrne pursued higher education at Cornell University, where he earned a Bachelor's degree.
  • He then completed a Medical Degree at SUNY Syracuse and finished a residency in Winthrop.
  • Maintaining professional affiliations to support excellence in his practice, the doctor is a member of FACOG, AOA, AMA, and MSSNY.

Michelle Bloom, MD, Named System Director of Cardio-Oncology at NYU Langone Health

Retrieved on: 
Thursday, December 14, 2023
NYU Langone Health, Cancer, Cardiology, Risk, Patient, Cardiovascular disease, Faculty, Internal medicine, The Stony Brook School, Culture, Heart failure, Division, Rutgers University, Montefiore Medical Center, NYU, Oncology, Publishing, Stony Brook University Hospital, Family, Estate (law), Health, Medical device, Nursing, Medicine, MD

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- A renowned expert in cardio-oncology and heart failure, Michelle Bloom, MD , has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients' heart health throughout cancer treatment and survivorship.

Key Points: 
  • NEW YORK, Dec. 13, 2023 /PRNewswire/ -- A renowned expert in cardio-oncology and heart failure, Michelle Bloom, MD , has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients' heart health throughout cancer treatment and survivorship.
  • She has a secondary appointment as clinical professor in the Department of Medicine , Leon H. Charney Division of Cardiology at NYU Grossman School of Medicine.
  • "Her experience as a clinician, educator, and researcher will further enhance the NYU Langone community.
  • As a well-recognized and accomplished heart failure specialist, Dr. Bloom will also continue a robust heart failure practice at several NYU Langone locations on Long Island, including NYU Langone Cardiology Associates—Mineola.

Brown Selected to Lead Golisano Institute for Developmental Disability Nursing

Retrieved on: 
Monday, October 30, 2023
Knowledge, Patient, St. John Fisher University, American Association on Intellectual and Developmental Disabilities, Disability, Intellectual, Multimedia, Curriculum, Disability studies, IDD, State university system, Mother Cabrini Health Foundation, University, Journal of Intellectual & Developmental Disability, Hospital, patients, health, territories, The Stony Brook School, Nursing

PITTSFORD, N.Y., Oct. 30, 2023 /PRNewswire/ -- St. John Fisher University has appointed Dr. Holly Brown as the new executive director of the Golisano Institute for Developmental Disability Nursing.

Key Points: 
  • PITTSFORD, N.Y., Oct. 30, 2023 /PRNewswire/ -- St. John Fisher University has appointed Dr. Holly Brown as the new executive director of the Golisano Institute for Developmental Disability Nursing.
  • Brown succeeds Dr. Dianne Cooney Miner, founding director of the Institute, who has moved into the role of senior advisor.
  • She joined the Institute in fall 2019 as the associate director and also serves as an associate professor in the Wegmans School of Nursing.
  • Brown is a member of the Alliance for Disability in Health Care Education; American Association on Intellectual and Developmental Disabilities; and Developmental Disabilities Nurses Association, among others.

The Inner Circle Acknowledges, Paul Byrne as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology

Retrieved on: 
Friday, August 18, 2023
Renaissance School of Medicine at Stony Brook University, Bachelor, Osteopathic medicine in the United States, Obstetrics, Education, New York Institute of Technology College of Osteopathic Medicine, State University of New York College of Environmental Science and Forestry, NYU, Multimedia, Private practice, FACOG, AOA, Inner circle, Philosophy, Medical degree, Patient, SUNY, AMA, Gynaecology, The Stony Brook School, Cornell University, Nursing, Medicine

MINEOLA, N.Y., Aug. 18, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul Byrne is acknowledged as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology.

Key Points: 
  • MINEOLA, N.Y., Aug. 18, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul Byrne is acknowledged as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of Obstetrics and Gynecology.
  • Dr. Byrne pursued higher education at Cornell University, where he earned a Bachelor's degree.
  • He then completed a Medical Degree at SUNY Syracuse and finished a residency in Winthrop.
  • Maintaining professional affiliations to support excellence in his practice, the doctor is a member of FACOG, AOA, AMA, and MSSNY.

AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors

Retrieved on: 
Thursday, April 6, 2023
Inflammation, Amgen, Laboratory, Drug development, Therapy, Pharmacia, Arthritis, Long Island University, Abbott, Abbott Laboratories, Nephrology, Staten Island University Hospital, CD122, State university system, Health, Akebia, Antibody, Pain, North Shore University Hospital, Metabolism, BTLA, Acquisition, AbbVie, SAN, Rheumatology, The Stony Brook School, Growth, G.D. Searle, LLC, PD-1, Autoimmunity, Pharmaceutical industry, Vaccine, Management, Medicine, Biology, Pfizer

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company’s Board of Directors, effective immediately.

Key Points: 
  • SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company’s Board of Directors, effective immediately.
  • Additionally, Laura J. Hamill has decided to resign from the company’s Board of Directors.
  • Also, Ms. Hamill has notified the company of her resignation from the company’s Board of Directors effective April 1, 2023.
  • The Board of Directors and the company’s management team would like to thank Ms. Hamill for her commitment to AnaptysBio and wish her well in her future endeavors.

Celldex Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

Retrieved on: 
Thursday, February 16, 2023
Inflammation, Divisional patent application, Health, Laboratory, Allergy, Abbott Laboratories, Therapy, Nephrology, North Shore University Hospital, Pain, Drug development, State university system, Acquisition, The Stony Brook School, Arthritis, Metabolism, Long Island University, Senior, Akebia, Pharmacia, State University of New York, G.D. Searle, LLC, Amgen, Renaissance School of Medicine at Stony Brook University, Abbott, AbbVie, Management, Pfizer

HAMPTON, N.J., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that it has appointed Rita Jain, M.D.

Key Points: 
  • HAMPTON, N.J., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that it has appointed Rita Jain, M.D.
  • “We are pleased to welcome Dr. Jain to the Celldex Board of Directors at this important time in the Company’s trajectory,” said Anthony Marucci, Co-founder, President and Chief Executive Officer of Celldex Therapeutics.
  • Dr. Jain currently serves as a member of the Board of Directors for Provention Bio, Inc. and serves on the supervisory board of AM Pharma.
  • She previously served on the Board of Directors of ChemoCentryx, Inc. until its acquisition by Amgen.

Allergist/Immunologist Misu Paul, MD to Join ENT and Allergy Associates, LLP In Bay Ridge and Dyker Heights Brooklyn, NY

Retrieved on: 
Wednesday, January 11, 2023
Otorhinolaryngology, Allergy, Teaching hospital, Internal medicine, Hindi, Asthma, American College of Allergy, Asthma and Immunology, Immunotherapy, American Board of Commissioners for Foreign Missions, Throat, American College, Ear, American Academy of Allergy, Asthma, and Immunology, Knowledge, Hives, Norwegian Asthma and Allergy Association, LLP, Patient, Baylor College of Medicine, American Academy, Atopic dermatitis, Allergist, Research, Audiology, Drug allergy, American Board of Internal Medicine, Dermatitis, Food allergy, Nose, Baylor University, The Stony Brook School, Immunology, Medical device, Adult, MD, Medicine

Dr. Paul is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology.

Key Points: 
  • Dr. Paul is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology.
  • Dr. Paul is active in the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
  • In Bay Ridge, Dr. Paul will work side-by-side with otolaryngologists Ramez Habib, MD, Christopher Song, MD, and Wesley Davidson, MD.
  • In Dyker Heights, she will join otolaryngologists Leon Chen, MD and Wayne Chung, MD.

Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors

Retrieved on: 
Thursday, January 5, 2023
AbbVie, Akebia, Nephrology, Abbott, Pain, Biotechnology, Shire (pharmaceutical company), Therapy, Drug development, Divisional Railway Hospital, Golden Rock, Pharmacia & Upjohn, North Shore University Hospital, Inflammation, Health, The Stony Brook School, BANK, Abbott Laboratories, Amgen, Acquisition, G.D. Searle, LLC, Arthritis, State university system, FDA, Laboratory, Pharmacia, Senior, RED, Metabolism, Pharmaceutical industry, Pfizer, Medicine, Biology

RED BANK, N.J., Jan. 5, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Rita Jain, M.D., to the Company's Board of Directors.

Key Points: 
  • RED BANK, N.J., Jan. 5, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Rita Jain, M.D., to the Company's Board of Directors.
  • "Rita brings extensive drug development experience to Provention Bio across a wide range of therapeutic areas including autoimmune and metabolic diseases," said Wayne Pisano, Chairman of the Board of Provention Bio.
  • Dr. Jain, a board-certified rheumatologist, currently serves as a member of the supervisory board of AM Pharma and previously served on the Board of Directors of ChemoCentryx, Inc. until its acquisition by Amgen.
  • Earlier in her career, Dr. Jain served as a faculty member at North Shore University Hospital in New York.

Surgical experts publish updated MRONJ guidance

Retrieved on: 
Tuesday, October 18, 2022
Quality of life, Dentist, Element, Disease, Medicine, Risk, Health care, The Stony Brook School, Infection, American Association of Oral and Maxillofacial Surgeons, UCLA School of Dentistry, Alveolar osteitis, Patient, Osteoporosis, Oral and maxillofacial surgery, Journal of Oral and Maxillofacial Surgery, Necrosis, University, MPH, Oncology, Jaw, Collection, Inflammation, Exhibition, Dental care, Knowledge, Dentistry, Immune system, Commonly used gamma-emitting isotopes, Rheumatology, Oral hygiene, Doctor of Philosophy, Extraction (chemistry), American Association, Oral, Degenerative disease, Association, Committee, Face, Sinusitis, Michigan Medicine, Carlson, Journal, EDM, Gingivitis, Head, Literature, Tobacco, AAOMS, North Memorial Health Hospital, Reconstructive surgery, Cancer, Algorithm, Medical device, MRONJ, DMD, MD, DRS, DDS

ROSEMONT, Ill., Oct. 18, 2022 /PRNewswire/ -- The American Association of Oral and Maxillofacial Surgeons (AAOMS) has issued updated guidance for treating a rare but potentially serious jawbone condition that can impact patients taking antiresorptive medications to treat certain cancer types.

Key Points: 
  • To help patients and healthcare providers navigate this clinical concern, oral and maxillofacial surgery experts analyzed literature and revised guidance to reflect current best practices.
  • Among strategies for reducing the risk of MRONJ: maintaining good oral hygiene, performing high-risk surgical procedures prior to initiating drug therapies, quitting smoking and optimizing diabetes care.
  • Surgical management of MRONJ is increasingly considered a viable method of treatment for all stages of the disease, according to the 2022 guidance.
  • A departure from the three previous position papers, the 2022 recommendations recognize the value of surgical intervention regardless of MRONJ disease stage.

The Ricco Dental Group Embraces Latest Dental Technologies, Launches New Website

Retrieved on: 
Monday, July 11, 2022
American Dental Association, Health, Teaching hospital, Diabetes, Disease, State university system, The Stony Brook School, Postgraduate training in general dentistry, Degenerative disease, Align Technology, Mental health, Mouth, Academy, Breast implant, Dental care, Technology, Learning, Dentistry, Patient, Academy of General Dentistry, North Shore University Hospital, Osseointegration

PLAINVIEW, N.Y., July 11, 2022 /PRNewswire-PRWeb/ -- To provide patients with the most comfortable, and advanced dental care available, The Ricco Dental Group uses the latest dental technologies, aimed at creating a relaxing patient experience, even for those who are fearful of going to the dentist. The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.

Key Points: 
  • The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.
  • The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.
  • That's our goal at The Ricco Dental Group: to help patients to achieve and maintain good oral health, thereby contributing to overall health and wellness," Dr. Ricco said.
  • The Ricco Dental Group is located at 709 S Oyster Bay Rd, Plainview, NY 11803.